The two antagonists for interleukin-1 (IL-1) system are IL-1α, and IL-1β. IL-1 receptor antagonist (IL-1RA) is another naturally occurring non-competitive antagonist. All three antagonists are bound to two receptors that are IL-R1 and IL-1R2. IL-1 is a well-studied pro-inflammatory cytokine that is involved in chronic inflammatory diseases such as rheumatoid arthritis, Parkinson's disease, Alzheimer's, stroke, and epilepsy. The existing literature suggests that interleukin-1 (IL-1) biological responses are impeded by interleukin-1 receptor antagonist (IL-1RA) belonging to interleukin-1 (IL-1) family and a natural IL-1 inhibitor acting as 'receptor antagonist'. Various studies based on different clinical and experimental models suggest that ILantagonism has been reported beneficial in neuropathalogical conditions, whereas, proinflammatory actions of IL-1 receptor antagonist (IL-1RA) seem detrimental. This study was performed to ameliorate the stability of IL-1RA mutants generated by mutagenesis at specific sites like R 6 K 7-AA, R 93 K 94-AA and K 97 R 98-AA. Using pTIG-Trx expression system, mutants were expressed in E. coli BL21 (DE3) accompanied with the induction of (isopropyl β-D-1thiogalactopyranoside) IPTG. Later on, the purification of recombinant proteins was brought about using SephadexG75 gel filtration chromatography and Ni +2 chelate chromatography. The bioactivity assay result exhibited IL-IRA activity as high as mutants' activity. The characterization of pharmacokinetic profile of IL-1RA apace with its mutants presents the half-life of third mutants 2.11 times longer than that of wt IL-1RA. This experimental study will lead to novel approaches, experiences and baseline data, thus providing basis for further research to outdo and elevate the metabolic stability of IL-1RA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.